Dendrix 0.3 – Discovery of Mutated Driver Pathways in Cancer

Dendrix 0.3

:: DESCRIPTION

Dendrix (De novo Driver Exclusivity) is an algorithm for discovery of mutated driver pathways in cancer using only mutation data. It finds sets of genes, domains, or nucleotides whose mutations exhibit both high coverage and high exclusivity in the analyzed samples.

Advertisement

::DEVELOPER

Raphael Lab

:: SCREENSHOTS

N/A

:: REQUIREMENTS

:: DOWNLOAD

 Dendrix

:: MORE INFORMATION

Citation:

F. Vandin, E. Upfal, B.J. Raphael. (2011)
De novo Discovery of Mutated Driver Pathways in Cancer.
Genome Res. 2011 Jul 11

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Exit mobile version